Malignant Tumor Clinical Trials in Chengdu, Sichuan
5 recruitingChengdu, Sichuan, China
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting
Phase 1
Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies
Malignant Tumors
Sichuan University20 enrolled1 locationNCT07004244
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163
Recruiting
Not Applicable
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
Randomized Controlled TrialMalignant Tumor of Liver
West China Hospital100 enrolled1 locationNCT06219096
Recruiting
Phase 2
A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
MSI-H Solid Malignant Tumor
Shanghai Henlius Biotech108 enrolled33 locationsNCT03941574